Submitted:
16 June 2026
Posted:
17 June 2026
You are already at the latest version
Abstract
The increasing prevalence of antimicrobial resistance and oxidative stress-related disorders necessitates the search for alternative, plant-based therapeutic agents. This study evaluated the phytochemical, antioxidant and antimicrobial activity of Hymenocardia acida and Phyllantus amarus extracts against clinical isolates. The phytochemical composition was evaluated using qualitative and quantitative assay, antioxidant activity using DPPH and FRAP assay, antimicrobial efficacy of Hymenocardia acida and Phyllanthus amarus leaf extracts, using methanol, chloroform, and n-hexane as extraction solvents and MIC was evaluated using microbroth diffusion method. Qualitative screening revealed the presence of key secondary metabolites such as alkaloids, flavonoids, phenols, tannins, saponins, terpenoids, and cardiac glycosides in varying abundance. Quantitative analysis showed that P. amarus methanol extract had the highest total phenol content (125.51 ± 0.80 mg GAE/g), while H. acida recorded higher flavonoid content (41.50 ± 0.09 mg QE/g). Antioxidant assays demonstrated that the methanol extracts of both plants exhibited the strongest DPPH radical scavenging activity, with P. amarus showing 78.15% inhibition and H. acida 57.64% at 500 µg/mL. The FRAP results further confirmed the antioxidant capacity, particularly in the methanol extracts. Antimicrobial evaluation against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Candida spp. revealed that methanol extracts were most effective, with inhibition zones up to 12.4 mm for P. amarus and 10.8 mm for H. acida. The Minimum Inhibitory Concentration (MIC) tests highlighted the chloroform fraction of H. acida as the most potent, with MICs as low as 3.12 µg/mL against S. aureus and Klebsiella spp. These findings underscore the therapeutic potential of both Hymenocardia acida and Phyllanthus amarus, supporting their ethnomedicinal uses and providing a scientific basis for their development into natural antioxidant and antimicrobial agents. Further studies on compound isolation and in vivo validation are recommended.
Keywords:
1. Introduction
- To obtain the extract of Phyllantus amarus and Hymenocardia acida extracts using maceration extraction method.
- To determine the antioxidant level of Phyllantus amarus and Hymenocardia acida extracts against isolates obtained from clinical samples
- To compare the antimicrobial potency of Phyllantus amarus and Hymenocardia acida against organism isolated from clinical samples.
- To assess the phytochemical constituents of the extracts of Phyllantus amarus and Hymenocardia acida in comparison using standard protocols.
2. Materials and Methodology
Collection and Preparation of Samples
Microorganisms Used
Preparation of Media
Preparation of Hymenocardia Acida and Phyllantus Amarus Extracts
Fractionation of the Crude Extracts
Determination of Phytochemical Constituents in Crude Extracts
Test for Alka Loids
Test for Tannins
Test for Saponins
Test for Steroids
Test for Flavonoids
Test for Terpenoids
Test for Polyphenols
Determination of Total Phenolic Content
Determination of Total Flavonoid Content
Determination of Antioxidant Using Two Parameters
DPPH Scavenging Activity
Ferric Ion Reducing Antioxidant Power Assay (FRAP)
Preparation of 5% Mcfarland’s Standard
Preparation of Bacterial and Fungal Suspensions
Determination of Antimicrobial Activity
Serial Dilution of Extracts
- 1 mL of each stock extract solution (previously reconstituted in a minimal volume of methanol) was added to Tube 1 and mixed thoroughly to achieve a 10⁻¹ dilution.
- 1 mL from Tube 1 was transferred to Tube 2 and mixed to make a 10⁻² dilution.
- This process was repeated through Tube 5, yielding serial dilutions from 10⁻¹ to 10⁻⁵.
- The procedure was repeated separately for each of the three extracts fractions for both plants (methanol, n-hexane, and chloroform).
| Tube Number | Volume of Extract Solution Added (mL) | Volume of Distilled Water (mL) | Final Dilution Factor |
| Tube 1 | 1.0 | 9.0 | 10⁻¹ |
| Tube 2 | 1.0 (from Tube 1) | 9.0 | 10⁻² |
| Tube 3 | 1.0 (from Tube 2) | 9.0 | 10⁻³ |
| Tube 4 | 1.0 (from Tube 3) | 9.0 | 10⁻⁴ |
| Tube 5 | 1.0 (from Tube 4) | 9.0 | 10⁻⁵ |
Minimum Inhibitory Concentration
Statistical Analyis
3. Results
Extraction of Leafs
Qualitative Phytochemical Screening of Crude Extracts
Antioxidant Determination of Crude Extracts Using
2,2-diphenyl-1-Picrylhydrazyl (DPPH) Radical Scavenging Assay
Ferric Reducing Antioxidant Power (FRAP) of Phyllanthus amarus and Hymenocardia acida
Total Phenol and Flavonoid Contents of Extracts of Phyllanthus Amarus and Hymenocardia Acida
Antimicrobial Activity of Phyllanthus amarus Extracts Against Selected Test Organisms
Antimicrobial Activity of Hymenocardia Acida Extracts Against Selected Test Organisms
Minimum Inhibitory Concentration (MIC) of Fractionated Extracts of Phyllanthus Amarus and Hymenocardia Acida Against Test Organisms
| Fractionated Extracts | Test Organisms | Minimum Inhibitory Concentration (MIC) |
| Phyllanthus amarus: | ||
| Methanol | Staphylococcus aureus | 100.00 |
| Escherichia coli | 50.00 | |
| Pseudomonas aureginosa | 25.00 | |
| Klebsiella spp | 10.00 | |
| Candida spp. | 100.00 | |
| n-Hexane | Staphylococcus aureus | 50.00 |
| Escherichia coli | 50.00 | |
| Pseudomonas aureginosa | 25.00 | |
| Klebsiella spp | 50.00 | |
| Candida spp. | 100.00 | |
| Chloroform | Staphylococcus aureus | 25.00 |
| Escherichia coli | 50.00 | |
| Pseudomonas aureginosa | 25.00 | |
| Klebsiella spp | 50.00 | |
| Candida spp. | 25.00 | |
| Control | Staphylococcus aureus | 100.00 |
| Escherichia coli | 50.00 | |
| Pseudomonas aureginosa | 100.00 | |
| Klebsiella spp | 100.00 | |
| Candida spp. | 100.00 |
| Fractionated Extracts | Test Organisms | Minimum Inhibitory Concentration (MIC) |
| Hymenocardia acida | ||
| Methanol | Staphylococcus aureus | 50.00 |
| Escherichia coli | 100.00 | |
| Pseudomonas aureginosa | 50.00 | |
| Klebsiella spp | 12.5 | |
| Candida spp. | 100.00 | |
| n-Hexane | Staphylococcus aureus | 12.5 |
| Escherichia coli | 25.00 | |
| Pseudomonas aureginosa | 50.00 | |
| Klebsiella spp | 6.50 | |
| Candida spp. | 25.00 | |
| Chloroform | Staphylococcus aureus | 3.12 |
| Escherichia coli | 12.50 | |
| Pseudomonas aureginosa | 6.50 | |
| Klebsiella spp | 3.12 | |
| Candida spp. | 50.00 | |
| Control | Candida spp | 25.00 |
4. Discussion
Conclusion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Abdallah, E. M.; Alhatlani, B. Y.; de Paula Menezes, R.; Martins, C. H. G. Back to nature: Medicinal plants as promising sources for antibacterial drugs in the post-antibiotic era. Plants 2023, 12(17), 3077. [Google Scholar] [CrossRef] [PubMed]
- Abu, A. H.; Uchendu, C. N. Antispermatogenic effects of aqueous ethanolic extract of Hymenocardia acida stem bark in male Wistar rats. J. Med. Plants Res. 2011, 5(13), 2795–2801. [Google Scholar] [CrossRef]
- Abubakar, A. R.; Haque, M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. J. Pharm. Bioallied Sci. 2020, 12(1), 1–10. [Google Scholar] [CrossRef] [PubMed]
- Agishi, E. C. A Tiv-English dictionary of plant names; Valley Printing and Publishing Company, 2004. [Google Scholar]
- Akinyemi, K. O.; Mendie, U. E.; Smith, S. T.; Oyefolu, A. O.; Coker, A. O. Screening of some Nigerian medicinal plants for antibacterial activity against Salmonella typhi and Salmonella paratyphi. Res. Complement. Med. 2005, 12(1), 26–32. [Google Scholar] [CrossRef]
- Cai, Y.; Luo, Q.; Sun, M.; Corke, H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci. 2004, 74(17), 2157–2184. [Google Scholar] [CrossRef] [PubMed]
- Dar, R. A.; Shahnawaz, M.; Qazi, P. H. General overview of medicinal plants: A review. J. Phytopharm. 2017, 6(6), 349–351. [Google Scholar] [CrossRef]
- Eze, F. I.; Nwodo, J. N.; Omeje, E. O. Evaluation of antimicrobial and antifungal activities of secondary metabolites from selected Nigerian medicinal plants. J. Basic Clin. Pharm. 2021, 12(3), 44–51. [Google Scholar]
- Farias, D. F.; Souza, T. M.; Viana, M. P.; Soares, B. M.; Cunha, A. P.; Vasconcelos, I. M.; Ricardo, N. M. P. S.; Ferreira, P. M. P.; Melo, V. M. M.; Carvalho, A. F. U. Antibacterial, antioxidant, and anticholinesterase activities of plant seed extracts from Brazilian semiarid region. An. Da Acad. Bras. De Ciências 2014, 86(3), 1195–1210. [Google Scholar] [CrossRef]
- Haruna, A.; Pateh, U. U.; Sule, M.; Musa, A. M.; Sani, Y. M.; Mohammed, M.; Lawal, M. D.; Garba, M. A. Evaluation of anticonvulsant activity of methanol leaf extract of Hymenocardia acida, Tul (Euphorbiaceae) in laboratory animals. J. Pharm. Allied Sci. 2017, 14(5), 2540–2547. [Google Scholar]
- Oboh, G.; Puntel, R. L.; Rocha, J. B. Hot pepper (Capsicum annuum, Tepin and Capsicum chinense, Habanero) prevents Fe2+-induced lipid peroxidation in brain—in vitro. Food Chem. 2007, 102(1), 178–185. [Google Scholar] [CrossRef]
- Ogbunugafor, H. A.; Eneh, F. U.; Ozumba, A. N.; Igwo-Ezikpe, M. N.; Okpuzor, J.; Pagano, I.; Kane, S. T. Physico-chemical and antioxidant properties of Hymenocardia acida King. Int. J. Pharmacol. 2011, 7(2), 238–245. [Google Scholar] [CrossRef]
- Ogunyemi, S. O.; Abdallah, Y.; Zhang, M.; Fouad, H.; Hong, X.; Ibrahim, E.; Masum, M. M. I.; Hossain, A.; Mo, J.; Li, B. Green synthesis of zinc oxide nanoparticles using plant extracts and their antibacterial mechanisms against clinical pathogens. Front. Microbiol. 2022, 13, Article 856329. [Google Scholar] [CrossRef]
- Okokon, J. E.; Bawo, M. B.; Mbagwu, H. Evaluation of antimalarial, antioxidant and antimicrobial activities of fractions of Mammea africana. Bangladesh J. Pharmacol. 2019, 14(2), 77–86. [Google Scholar]
- Oluba, O. M.; Adebisi, K. E.; Eidangbe, G. O.; Ojieh, A. E. Phytochemical composition and antioxidant status of Phyllanthus amarus aqueous extract in alloxan-induced diabetic rats. J. Diet. Suppl. 2020, 17(4), 436–447. [Google Scholar] [CrossRef]
- Panche, A. N.; Diwan, A. D.; Chandra, S. R. Flavonoids: An overview. J. Nutr. Sci. 5 2016, e47. [Google Scholar] [CrossRef] [PubMed]
- Prasad, K. N.; Yang, B.; Shi, J.; Yu, C.; Zhao, M.; Xue, S.; Jiang, Y. Effect of extraction solvent and technique on the total phenolic content and antioxidant activity of litchi (Litchi chinensis Sonn.) fruit pericarp. Food Chem. 2011, 126(3), 1331–1337. [Google Scholar] [CrossRef]
- Silva, N. C. C.; Fernandes Júnior, A. Biological properties of medicinal plants: A review of their antimicrobial activity. J. Venom. Anim. Toxins Incl. Trop. Dis. 2010, 16(3), 402–413. [Google Scholar] [CrossRef]
- Sofidiya, M. O. Phytochemical and pharmacological evaluation of Hymenocardia acida Tul. (Hymenocardiaceae) leaves. Doctoral dissertation, University of Lagos, 2008. [Google Scholar]
- Sofowora, A. Medicinal plants and traditional medicine in Africa, 2nd ed.; Spectrum Books Ltd, 1993. [Google Scholar]
- Srivastava, R.; Singh, R. Herbal medicine: A review of its history, significance, and development in developing countries. Int. J. Green Pharm. 2016, 10(2), 67–75. [Google Scholar] [CrossRef]
- Stumbo, P.; Feld, R.; Evans, W.; Weiner, R.; Moran, E.; Hoffman, F. A. The historical pursuit of natural analgesics and antimicrobials. J. Ethnopharmacol. 2017, 204, 89–101. [Google Scholar]
- Tungmunnithum, D.; Thongboonyou, A.; Pholboon, A.; Yangsabai, A. Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical applications: An overview. Medicines 2018, 5(3), 93. [Google Scholar] [CrossRef] [PubMed]
- Ugbogu, O. C.; Emmanuel, O.; Agi, G. O.; Ibe, C.; Ekweogu, C. N.; Ude, V. C.; Ugbogu, E. A. A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.). Heliyon 2021, 7(11), e08404. [Google Scholar] [CrossRef] [PubMed]
- Ukaegbu-Obi, K. M.; Mereni, C. I.; Oji, O. O. Antimicrobial activity of selected medicinal plants against clinical pathogens. Int. J. Microbiol. Biotechnol. 2018, 3(2), 34–41. [Google Scholar]
- Yessuf, A. M. Phytochemical screening and evaluation of biological activities of selected medicinal plants. J. Pharmacogn. Phytochem. 2015, 4(3), 112–118. [Google Scholar]
- Yusuf, I.; Arzai, A. H.; Umar, A. M.; Haruna, M.; Yusuf, N. Characterization and antimicrobial susceptibility profile of bacteraemia causing pathogens isolated from febrile children in Kano, Nigeria. Bayero J. Pure Appl. Sci. 2018, 11(1), 143–151. [Google Scholar] [CrossRef]




| Leaf Extracts | Gram (g) |
| Hymenocardia acida | 700 |
| Phyllantus amarus | 93.5 |
| Chemical Compounds (Phytochemicals) | Phyllanthus amarus Extract | Hymenocardia acida Extract |
| Saponin | ++ | ++ |
| Alkaloid | +++ | ++ |
| Flavonoid | +++ | +++ |
| Tannin | + | ++ |
| Phenol | +++ | ++ |
| Coumarin | ++ | ++ |
| Terpenoid | ++ | + |
| Steroid | ++ | ++ |
| Diterpenes | ++ | + |
| Cardiac Glycosides | ++ | + |
| Extracts | Total Flavonoid Content (QE/mg/g) Mean ± SD |
Total Phenol Content (GAE/mg/g) Mean ± SD |
| Phyllanthus amarus | 21.75± 0.23 | 66.39 ± 0.59 |
| Hymenocardia acida | 28.50 ± 0.11 | 49.01 ± 0.47 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).